• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.62% Nasdaq Up0.35%

    Hemispherx Biopharma, Inc. (HEB)

    -NYSE MKT
    0.12 Up 0.01(7.96%) Feb 10, 4:00PM EST
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 197   150   213  
    Cost of Revenue1,251  1,234  1,989  
    Gross Profit (1,054) (1,084) (1,776)
    Operating Expenses
    Research Development8,988  8,360  9,508  
    Selling General and Administrative9,057  7,723  9,056  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (19,099) (17,167) (20,340)
    Income from Continuing Operations
    Total Other Income/Expenses Net1,660  958  3,010  
    Earnings Before Interest And Taxes(17,439)(16,209)(17,330)
    Interest Expense11  16  24  
    Income Before Tax(17,450)(16,225)(17,354)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(17,450)(16,225)(17,354)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (17,450) (16,225) (17,354)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (17,450) (16,225) (17,354)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.